KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Danaher (DHR) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Danaher (DHR) over the last 17 years, with Q3 2025 value amounting to $1.5 billion.

  • Danaher's Cash & Equivalents fell 4183.48% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year decrease of 4183.48%. This contributed to the annual value of $2.1 billion for FY2024, which is 6456.34% down from last year.
  • Latest data reveals that Danaher reported Cash & Equivalents of $1.5 billion as of Q3 2025, which was down 4183.48% from $3.0 billion recorded in Q2 2025.
  • In the past 5 years, Danaher's Cash & Equivalents registered a high of $12.3 billion during Q3 2023, and its lowest value of $1.5 billion during Q3 2025.
  • In the last 5 years, Danaher's Cash & Equivalents had a median value of $4.0 billion in 2022 and averaged $4.9 billion.
  • As far as peak fluctuations go, Danaher's Cash & Equivalents soared by 13838.83% in 2023, and later crashed by 7860.23% in 2024.
  • Quarter analysis of 5 years shows Danaher's Cash & Equivalents stood at $2.6 billion in 2021, then surged by 131.83% to $6.0 billion in 2022, then decreased by 2.19% to $5.9 billion in 2023, then plummeted by 64.56% to $2.1 billion in 2024, then dropped by 26.47% to $1.5 billion in 2025.
  • Its Cash & Equivalents stands at $1.5 billion for Q3 2025, versus $3.0 billion for Q2 2025 and $2.0 billion for Q1 2025.